IBDEI05B ; ; 18-FEB-2009
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 18, 2009
 Q:'DIFQR(358.3)  F I=3D1:2 S X=3D$T(Q+I) Q:X=3D""  S
Y=3D$E($T(Q+I+1),4,999),X=3D$E(X,4,999) S:$A(Y)=3D126
I=3DI+1,Y=3D$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=3D61 Y=3D$E(Y,2,999) =
X NO E
S @X=3DY
Q Q
 ;;^UTILITY(U,$J,358.3,5502,1,8,0)
 ;;=3D8^Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,5502,2)
 ;;=3D^93357
 ;;^UTILITY(U,$J,358.3,5503,0)
 ;;=3D287.5^^50^425^4
 ;;^UTILITY(U,$J,358.3,5503,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5503,1,1,0)
 ;;=3D1^287.5
 ;;^UTILITY(U,$J,358.3,5503,1,8,0)
 ;;=3D8^Thrombocytopenia Nos
 ;;^UTILITY(U,$J,358.3,5503,2)
 ;;=3D^118988
 ;;^UTILITY(U,$J,358.3,5504,0)
 ;;=3D287.1^^50^425^3
 ;;^UTILITY(U,$J,358.3,5504,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5504,1,1,0)
 ;;=3D1^287.1
 ;;^UTILITY(U,$J,358.3,5504,1,8,0)
 ;;=3D8^Qualitative Platelet Defects
 ;;^UTILITY(U,$J,358.3,5504,2)
 ;;=3D^101922
 ;;^UTILITY(U,$J,358.3,5505,0)
 ;;=3D287.30^^50^425^2
 ;;^UTILITY(U,$J,358.3,5505,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5505,1,1,0)
 ;;=3D1^287.30
 ;;^UTILITY(U,$J,358.3,5505,1,8,0)
 ;;=3D8^Primary Thrombocytopenia (ITP)
 ;;^UTILITY(U,$J,358.3,5505,2)
 ;;=3D^332841
 ;;^UTILITY(U,$J,358.3,5506,0)
 ;;=3D238.71^^50^425^7
 ;;^UTILITY(U,$J,358.3,5506,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5506,1,1,0)
 ;;=3D1^238.71
 ;;^UTILITY(U,$J,358.3,5506,1,8,0)
 ;;=3D8^Thrombocytosis,Essential
 ;;^UTILITY(U,$J,358.3,5506,2)
 ;;=3D^334027
 ;;^UTILITY(U,$J,358.3,5507,0)
 ;;=3D205.00^^50^426^1
 ;;^UTILITY(U,$J,358.3,5507,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5507,1,1,0)
 ;;=3D1^205.00
 ;;^UTILITY(U,$J,358.3,5507,1,8,0)
 ;;=3D8^A M L, W/O Remission
 ;;^UTILITY(U,$J,358.3,5507,2)
 ;;=3D^267531
 ;;^UTILITY(U,$J,358.3,5508,0)
 ;;=3D205.01^^50^426^2
 ;;^UTILITY(U,$J,358.3,5508,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5508,1,1,0)
 ;;=3D1^205.01
 ;;^UTILITY(U,$J,358.3,5508,1,8,0)
 ;;=3D8^A M L,In Remission
 ;;^UTILITY(U,$J,358.3,5508,2)
 ;;=3D^267532
 ;;^UTILITY(U,$J,358.3,5509,0)
 ;;=3D205.10^^50^426^5
 ;;^UTILITY(U,$J,358.3,5509,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5509,1,1,0)
 ;;=3D1^205.10
 ;;^UTILITY(U,$J,358.3,5509,1,8,0)
 ;;=3D8^C M L,W/O Remission
 ;;^UTILITY(U,$J,358.3,5509,2)
 ;;=3D^267533
 ;;^UTILITY(U,$J,358.3,5510,0)
 ;;=3D205.11^^50^426^4
 ;;^UTILITY(U,$J,358.3,5510,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5510,1,1,0)
 ;;=3D1^205.11
 ;;^UTILITY(U,$J,358.3,5510,1,8,0)
 ;;=3D8^C M L,In Remission
 ;;^UTILITY(U,$J,358.3,5510,2)
 ;;=3D^267534
 ;;^UTILITY(U,$J,358.3,5511,0)
 ;;=3D289.0^^50^426^8
 ;;^UTILITY(U,$J,358.3,5511,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5511,1,1,0)
 ;;=3D1^289.0
 ;;^UTILITY(U,$J,358.3,5511,1,8,0)
 ;;=3D8^Secondary Polycythemia
 ;;^UTILITY(U,$J,358.3,5511,2)
 ;;=3D^186856
 ;;^UTILITY(U,$J,358.3,5512,0)
 ;;=3D238.4^^50^426^7
 ;;^UTILITY(U,$J,358.3,5512,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5512,1,1,0)
 ;;=3D1^238.4
 ;;^UTILITY(U,$J,358.3,5512,1,8,0)
 ;;=3D8^Polycythemia Rubra Vera
 ;;^UTILITY(U,$J,358.3,5512,2)
 ;;=3D^96105
 ;;^UTILITY(U,$J,358.3,5513,0)
 ;;=3D288.9^^50^426^9
 ;;^UTILITY(U,$J,358.3,5513,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5513,1,1,0)
 ;;=3D1^288.9
 ;;^UTILITY(U,$J,358.3,5513,1,8,0)
 ;;=3D8^Unspecified Dis Of W B C
 ;;^UTILITY(U,$J,358.3,5513,2)
 ;;=3D^267993
 ;;^UTILITY(U,$J,358.3,5514,0)
 ;;=3D289.81^^50^426^3
 ;;^UTILITY(U,$J,358.3,5514,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5514,1,1,0)
 ;;=3D1^289.81
 ;;^UTILITY(U,$J,358.3,5514,1,8,0)
 ;;=3D8^Blood Diseases
 ;;^UTILITY(U,$J,358.3,5514,2)
 ;;=3D^329886
 ;;^UTILITY(U,$J,358.3,5515,0)
 ;;=3D238.75^^50^426^6
 ;;^UTILITY(U,$J,358.3,5515,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5515,1,1,0)
 ;;=3D1^238.75
 ;;^UTILITY(U,$J,358.3,5515,1,8,0)
 ;;=3D8^Myelodysplastic Syndrome
 ;;^UTILITY(U,$J,358.3,5515,2)
 ;;=3D^334031
 ;;^UTILITY(U,$J,358.3,5516,0)
 ;;=3D204.00^^50^427^2
 ;;^UTILITY(U,$J,358.3,5516,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5516,1,1,0)
 ;;=3D1^204.00
 ;;^UTILITY(U,$J,358.3,5516,1,8,0)
 ;;=3D8^A L L,W/O Remission
 ;;^UTILITY(U,$J,358.3,5516,2)
 ;;=3D^267521
 ;;^UTILITY(U,$J,358.3,5517,0)
 ;;=3D204.01^^50^427^1
 ;;^UTILITY(U,$J,358.3,5517,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5517,1,1,0)
 ;;=3D1^204.01
 ;;^UTILITY(U,$J,358.3,5517,1,8,0)
 ;;=3D8^A L L, In Remission
 ;;^UTILITY(U,$J,358.3,5517,2)
 ;;=3D^267522
 ;;^UTILITY(U,$J,358.3,5518,0)
 ;;=3D204.10^^50^427^4
 ;;^UTILITY(U,$J,358.3,5518,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5518,1,1,0)
 ;;=3D1^204.10
 ;;^UTILITY(U,$J,358.3,5518,1,8,0)
 ;;=3D8^C L L,W/O Remission
 ;;^UTILITY(U,$J,358.3,5518,2)
 ;;=3D^267523
 ;;^UTILITY(U,$J,358.3,5519,0)
 ;;=3D204.11^^50^427^3
 ;;^UTILITY(U,$J,358.3,5519,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5519,1,1,0)
 ;;=3D1^204.11
 ;;^UTILITY(U,$J,358.3,5519,1,8,0)
 ;;=3D8^C L L,In Remission
 ;;^UTILITY(U,$J,358.3,5519,2)
 ;;=3D^267524
 ;;^UTILITY(U,$J,358.3,5520,0)
 ;;=3D201.90^^50^427^6
 ;;^UTILITY(U,$J,358.3,5520,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5520,1,1,0)
 ;;=3D1^201.90
 ;;^UTILITY(U,$J,358.3,5520,1,8,0)
 ;;=3D8^Hodgkins Lymphoma,Unspec Type
 ;;^UTILITY(U,$J,358.3,5520,2)
 ;;=3D^267430
 ;;^UTILITY(U,$J,358.3,5521,0)
 ;;=3D202.00^^50^427^7
 ;;^UTILITY(U,$J,358.3,5521,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5521,1,1,0)
 ;;=3D1^202.00
 ;;^UTILITY(U,$J,358.3,5521,1,8,0)
 ;;=3D8^Lymphoma, Low-Grade (Nodular)
 ;;^UTILITY(U,$J,358.3,5521,2)
 ;;=3D^72606
 ;;^UTILITY(U,$J,358.3,5522,0)
 ;;=3D200.20^^50^427^8
 ;;^UTILITY(U,$J,358.3,5522,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5522,1,1,0)
 ;;=3D1^200.20
 ;;^UTILITY(U,$J,358.3,5522,1,8,0)
 ;;=3D8^Lymphoma,Burkitts
 ;;^UTILITY(U,$J,358.3,5522,2)
 ;;=3D^17529
 ;;^UTILITY(U,$J,358.3,5523,0)
 ;;=3D202.10^^50^427^15
 ;;^UTILITY(U,$J,358.3,5523,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5523,1,1,0)
 ;;=3D1^202.10
 ;;^UTILITY(U,$J,358.3,5523,1,8,0)
 ;;=3D8^Mycosis Fungoides
 ;;^UTILITY(U,$J,358.3,5523,2)
 ;;=3D^80360
 ;;^UTILITY(U,$J,358.3,5524,0)
 ;;=3D273.3^^50^427^11
 ;;^UTILITY(U,$J,358.3,5524,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5524,1,1,0)
 ;;=3D1^273.3
 ;;^UTILITY(U,$J,358.3,5524,1,8,0)
 ;;=3D8^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,5524,2)
 ;;=3D^73013
 ;;^UTILITY(U,$J,358.3,5525,0)
 ;;=3D203.00^^50^427^14
 ;;^UTILITY(U,$J,358.3,5525,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5525,1,1,0)
 ;;=3D1^203.00
 ;;^UTILITY(U,$J,358.3,5525,1,8,0)
 ;;=3D8^Multiple Myeloma,W/O Remission
 ;;^UTILITY(U,$J,358.3,5525,2)
 ;;=3D^267514
 ;;^UTILITY(U,$J,358.3,5526,0)
 ;;=3D203.01^^50^427^13
 ;;^UTILITY(U,$J,358.3,5526,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5526,1,1,0)
 ;;=3D1^203.01
 ;;^UTILITY(U,$J,358.3,5526,1,8,0)
 ;;=3D8^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,5526,2)
 ;;=3D^267515
 ;;^UTILITY(U,$J,358.3,5527,0)
 ;;=3D202.40^^50^427^5
 ;;^UTILITY(U,$J,358.3,5527,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5527,1,1,0)
 ;;=3D1^202.40
 ;;^UTILITY(U,$J,358.3,5527,1,8,0)
 ;;=3D8^Hairy-Cell Leukemia
 ;;^UTILITY(U,$J,358.3,5527,2)
 ;;=3D^69587
 ;;^UTILITY(U,$J,358.3,5528,0)
 ;;=3D200.10^^50^427^9
 ;;^UTILITY(U,$J,358.3,5528,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5528,1,1,0)
 ;;=3D1^200.10
 ;;^UTILITY(U,$J,358.3,5528,1,8,0)
 ;;=3D8^Lymphoma,Int/High (Diffuse)
 ;;^UTILITY(U,$J,358.3,5528,2)
 ;;=3D^175886
 ;;^UTILITY(U,$J,358.3,5529,0)
 ;;=3D273.1^^50^427^12
 ;;^UTILITY(U,$J,358.3,5529,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5529,1,1,0)
 ;;=3D1^273.1
 ;;^UTILITY(U,$J,358.3,5529,1,8,0)
 ;;=3D8^Monoclon Paraproteinemia
 ;;^UTILITY(U,$J,358.3,5529,2)
 ;;=3D^78888
 ;;^UTILITY(U,$J,358.3,5530,0)
 ;;=3D238.79^^50^427^10
 ;;^UTILITY(U,$J,358.3,5530,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5530,1,1,0)
 ;;=3D1^238.79
 ;;^UTILITY(U,$J,358.3,5530,1,8,0)
 ;;=3D8^Lymphoproliferat Dis
 ;;^UTILITY(U,$J,358.3,5530,2)
 ;;=3D^334033
 ;;^UTILITY(U,$J,358.3,5531,0)
 ;;=3D156.2^^50^428^1
 ;;^UTILITY(U,$J,358.3,5531,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5531,1,1,0)
 ;;=3D1^156.2
 ;;^UTILITY(U,$J,358.3,5531,1,8,0)
 ;;=3D8^Ampulla Of Vater
 ;;^UTILITY(U,$J,358.3,5531,2)
 ;;=3D^267100
 ;;^UTILITY(U,$J,358.3,5532,0)
 ;;=3D154.3^^50^428^2
 ;;^UTILITY(U,$J,358.3,5532,1,0)
 ;;=3D^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,5532,1,1,0)
 ;;=3D1^154.3
 ;;^UTILITY(U,$J,358.3,5532,1,8,0)
 ;;=3D8^Anus
